Highlights of ISC 2024, Trials and Future Innovations for Stroke Care: Tudor Jovin, MD; Lauren Sansing, MD, MS, FAHA

Commentary
Video

The medical director of the Cooper Neurological Institute and the professor of neurology at Yale University School of Medicine shared a few highlights from research presented at ISC 2024. [WATCH TIME: 7 minutes]

WATCH TIME: 7 minutes

"In the evolving landscape of stroke care, embracing new conditions is not just a necessity but a pathway to enhancing patient well-being."

Over the past couple of decades, the stroke field has made continual progress for potential treatments and prevention approaches. At the 2024 International Stroke Conference (ISC), held February 7-9, in Phoenix, Arizona, clinicians presented their latest research in different areas of the field of stroke such as large vessel occlusion (LOV), subcranial hemorrhage, intracranial hemorrhage, ischemic stroke, and more. During the meeting, program chair Tudor Jovin, MD participated in several events of the conference which included moderating sessions, presenting awards, and giving closing remarks. In addition, vice chair Lauren Sansing, MD, MS, FAHA, also participated with Jovin as a moderator in the closing main event.

Of the many presentations given at the meeting, some of the most notable studies presented were late breakers. In one of the late breaking presentations, findings from the GOLDEN BRIDGE II trial (NCT04524624) showed that the use of an artificial intelligence (AI)-based clinical decision support system, also known as AI-CDSS, had a significantly greater impact on the number of vascular events and stroke care quality than standard care in patients with acute ischemic stroke.1 Another late breaker from the ZODIAC trial demonstrated that 0-degree head positioning imparted stability and clinical improvement in patients with LVO thrombectomy.2

On the final day of the meeting, Jovin, medical director at Cooper Neurological Institute, and Sansing, professor of neurology at Yale University School of Medicine, sat down with NeurologyLive® in an interview to share their medical perspective on some of the highlights from the presented research. Jovin, who also serves as the chairman and chief of neurology at Cooper University Health Care, talked about the wider implications of the GOLDEN BRIDGE II where AI outperformed humans in stroke diagnosis. Sansing, the future program chair, spoke about how the stroke intervention from ZODIAC of simple head position adjustment shows promise in thrombectomy procedures for patients. In addition, both discussed how sessions at the meeting are bridging the gap between basic scientists and clinicians in stroke research.

Click here for more coverage of ISC 2024.

REFERENCES
1. Zhang X, Ding L, Jing J, et al. Effect of an artificial intelligence-based clinical decision support system on stroke care quality and outcomes in patients with acute ischemic stroke (Golden Bridge II): a cluster-randomized clinical trial. Presented at: International Stroke Conference; February 7-9, 2024; Abstract LB15.
2. Alexandrov AW, Shearin AJ, Torrealba-Acosta G, et al. Zero Degree Head Positioning in Acute Large Vessel Ischemic Stroke (ZODIAC). Presented at: 2024 International Stroke Conference; February 7-9; Phoenix, AZ. Abstract LB1.
Related Videos
Kevin Church, PhD
Merit Cudkowicz, MD, MSc
Jessica Ailani, MD
Frederic Schaper, MD, PhD
Jaime Imitol, MD
Jason M. Davies, MD, PhD
Carolyn Bernstein, MD
© 2024 MJH Life Sciences

All rights reserved.